Loading Events

« All Events

 

Synopsis

Singapore’s healthcare system leads the world in terms of efficient and favourable patient outcomes. But the pressures exerted by an ageing population with high longevity, demand for increasingly high-technology treatments, heavy reliance on public healthcare, and the growing frequency of epidemic diseases underscore the need to reinforce and future-proof the healthcare system. 

To become sustainable, healthcare systems may limit the breadth of population coverage by instituting means-tested access to publicly financed health care, limit the scope of publicly financed benefits to which people are entitled by rationing health care resources, or limit the depth of publicly financed coverage by introducing or increasing price rationing, all while improving stewardship of resources.

How can Singapore maintain its position as a leading provider of cost-efficient and clinically-effective healthcare solutions to all citizens?  How can non-traditional actors intervene to ensure the sustainability of healthcare systems?  What lies at the intersection of healthcare and private finance? 

This March, EuroCham makes the case for a more sustainable healthcare financing mechanism for Singapore, based on stakeholder capitalism, investing for social impact, and more effective risk-pooling mechanisms.

 

Programme

4.20 pm Webinar Waiting Room Opens

4.30 pm Opening Remarks by Ms Nele CORNELIS, Executive Director, EuroCham

4.35 pm Presentations

  • Dr Eugene HONG, Executive Director of Institutional Banking Group, DBS Bank
  • Mr Samuel KOH, Corporate Affairs & Market Access Director, AstraZeneca
  • Mr Anbu SRINIVASAN, Managing Director, Fresenius Medical Care

5.15 pm Moderated Panel Discussion and Q&A by Mr Chris Hardesty, KPMG Services

5.55 pm Closing Remarks by Ms Nele CORNELIS, Executive Director, EuroCham

 

Speakers

Dr Eugene HONG
Executive Director of Institutional Banking Group
DBS Bank

Dr Eugene Hong joined DBS in 2016 and is currently Executive Director of Institutional Banking Group heading the Global Healthcare sector within DBS Bank. 

Dr Hong has more than 20 years of experience that spans across the healthcare value chain, he had taken up senior leadership positions at corporations such as Parkway, GE Healthcare, Novartis and National Australia Bank. His current role at DBS involves developing integrated financial services solutions for the healthcare industry including the milestone capital market activities in Asia. He is also leading a sustainable healthcare ecosystem drive especially with regards to healthcare payments. His current portfolio of clients includes major healthcare players within Asia as well as western multi-national corporates.

Dr Hong graduated from Monash University in Master Health Service Management & MBBS Medicine and has also obtained a Master of Science, Global Finance from New York University

 

Mr Samuel Koh
Director, Corporate Affairs & Market Access
AstraZeneca (Singapore) Pte. Ltd.

Mr Samuel Koh is currently Director, Corporate Affairs & Market Access for AstraZeneca (Singapore) Pte. Ltd. In his 17 years career in the pharmaceutical industry, he has built a wealth of commercial pharmaceutical experience, having held various leadership roles in sales, product management, market access, corporate affairs and communications.

In his current capacity where he sits as a member of the Country Leadership Team, Mr Koh is responsible for leading and overseeing the policy-shaping, market access and communication initiatives. He works with government agencies such as the Ministry of Health to explore access opportunities for AstraZeneca’s innovative portfolio of drugs to the larger Singapore population and also assess opportunities to establish private-public partnerships aiming at improving overall patients’ health outcomes. Samuel also sits as a member of the Public Policy Committee of the local pharmaceutical trade association, Singapore Association of Pharmaceutical Industries (SAPI), supporting the policy-related work at the industry level.

Mr Koh graduated from Murdoch University, Perth, W.A. Australia with a 1st Class Honours in Biomedical Science.

 

Mr Anbu SRINIVASAN
Managing Director
Fresenius Medical Care

Mr Srinivasan is a Managing Director at Fresenius Medical Care (FME), the world’s leading provider of products and services for people with chronic kidney failure. He manages the company’s Singapore and Brunei businesses. Mr Srinivasan has been with FME for over 3 years and was responsible for regional projects prior to this role. He has, over his career worked primarily in the Healthcare sector with corporates and consulting firms. Besides Singapore, Mr Srinivasan has lived & worked in India, Hong Kong and the UK. He holds an MBA from University of Oxford.

 

Moderator

Mr Chris HARDESTY
Director, Life Sciences
KPMG Services

As a member of KPMG’s Global Healthcare & Life Sciences Centre of Excellence, Mr Hardesty is presently based in Singapore looking after developments in the Asia-Pacific region. Prior postings have included Europe, US, and Brasil. With experience across a range of geographies and project types, his passion is public-private partnerships to drive innovative, safe, and economically-viable initiatives in the sector.  In addition, Mr Hardestry engages in adjunct lecturing, research/writing, and start-up/fund advisory so as to be a steward of innovation acceleration across the healthcare ecosystem. 

 

 


Student tickets are available for this event.

Students from partnering universities are invited to join, free of charge. Partnering universities; NUS, NTU, SMU, EDHEC, ESSEC & INSEAD.
There are limited student tickets available and are subject to correct registration details. 

  • Please sign up with your university-issued email address
  • Enter your institution under “company”
  • Enter your major/ programme under “designation” 
  • Select “Complimentary Student Ticket”

 

Registration Guidelines –

Please follow these simple steps for easy registration to our webinar.

Step 1: Register below. You will receive an automated registration confirmation email from EuroCham.

Step 2: Prior to the event, a Zoom link will be sent if payment has been received. (Payment by PayPal, PayNow/ PayLah/ QR Code preferred). Please watch out for this second email.

Step 3: Using the link provided in the second email, click on the link 15 minutes prior to the start of the event. 

Step 4: We will only admit attendees whose Zoom profiles match their registration names, so please make sure that your Zoom profile corresponds with your registration name. 

Thank you for your understanding.

Kindly note that there are limited seats available, registration is binding and payment is non-refundable. The organisers reserve the right to change the programme content without giving prior notification or any reasons thereof.